Research / ELA / Fundamental state Inspectable configuration
State dimensions Filing 0000701719-26-000017 General Corporate
Debt relative to revenue 30th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
17.03% · OPTIONAL · VALID
Capex intensity 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
1.70% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
10.42% · OPTIONAL · VALID
Revenue growth 30th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
3.46% · CORE · VALID
Inventory pressure 75th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
52.53% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
23.56% · CORE · VALID
Operating margin 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
8.99% · CORE · VALID
SBC intensity 90th Own-history percentile · N=10
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.00% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 30 states Self-history eligible
Sep 30, 2021 4/6 normalized Level 3 Dec 31, 2021 5/8 normalized Level 3 Mar 31, 2022 5/6 normalized Level 3 Jun 30, 2022 5/6 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/8 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/8 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Increased
Previous 9.96%
Current 17.03%
Delta 7.07% Capex Intensity Increased
Previous 0.58%
Current 1.70%
Delta 1.12% Cash Generation Decreased
Previous 21.50%
Current 10.42%
Delta -11.08% Growth Decreased
Previous 103.87%
Current 3.46%
Delta -100.42% Inventory Pressure Increased
Previous 34.57%
Current 52.53%
Delta 17.96% Margin Increased
Previous 20.96%
Current 23.56%
Delta 2.60% Profitability Decreased
Previous 11.40%
Current 8.99%
Delta -2.41% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Jun 30, 2025
Similarity 75%
Compared 8 dimensions
Coverage 100% Growth 27.9 · Margin 5.0 · Profitability 50.0 · Sbc Intensity 2.5 · Capex Intensity 25.0 · Cash Generation 30.0 · Inventory Pressure 0.0 · Balance Sheet Leverage 5.0 Mar 31, 2024
Similarity 71%
Compared 7 dimensions
Coverage 88% Growth 22.9 · Margin 38.3 · Profitability 51.1 · Capex Intensity 2.8 · Cash Generation 5.0 · Inventory Pressure 25.0 · Balance Sheet Leverage 26.3 Mar 31, 2022
Similarity 71%
Compared 5 dimensions
Coverage 63% Margin 15.0 · Profitability 40.0 · Capex Intensity 35.0 · Inventory Pressure 35.0 · Balance Sheet Leverage 7.5 Mar 31, 2023
Similarity 68%
Compared 7 dimensions
Coverage 88% Growth 10.0 · Margin 26.4 · Profitability 40.0 · Capex Intensity 67.9 · Cash Generation 13.2 · Inventory Pressure 10.7 · Balance Sheet Leverage 3.3 Sep 30, 2024
Similarity 68%
Compared 7 dimensions
Coverage 88% Growth 38.8 · Margin 20.0 · Profitability 70.0 · Capex Intensity 15.0 · Cash Generation 0.9 · Inventory Pressure 15.0 · Balance Sheet Leverage 7.8 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.